All In Biotech

Drug Trial Radar · NCT07664553

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin

A Randomized, Double-blind, Parallel-group Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus on Background Insulin (Eluminate-3)

Last checked: Nov 19, 2026Latest source record: Aug 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 600 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

600

Planned (sponsor's estimate)

Start

Jul 8, 2026

Primary completion

May 23, 2028

Study completion May 23, 2028

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
First posted
Jun 24, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron compared with placebo in adults with Type 2 Diabetes Mellitus (T2DM), treated with a background insulin and other background glucose-lowering medication(s)

Conditions

  • Type 2 Diabetes Mellitus

Interventions

  • ElecoglipronDrug

    Elecoglipron is administered orally once daily.

  • PlaceboDrug

    Placebo is administered orally once daily.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline in Hemoglobin A1c (HbA1c)Time frame: Baseline to Week 40

Locations

132 sites in 13 countries. Site status is shown where the registry gives one.

  • Research Site

    Little Rock, Arkansas · Not yet recruiting

  • Research Site

    Sacramento, California · Not yet recruiting

  • Research Site

    Aurora, Colorado · Not yet recruiting

  • Research Site

    DeLand, Florida · Suspended

  • Research Site

    Doral, Florida · Not yet recruiting

  • Research Site

    Ocoee, Florida · Recruiting

  • Research Site

    Decatur, Georgia · Not yet recruiting

  • Research Site

    Potomac, Maryland · Not yet recruiting

  • Research Site

    Brooklyn, New York · Suspended

  • Research Site

    Cary, North Carolina · Not yet recruiting

  • Research Site

    Morehead City, North Carolina · Not yet recruiting

  • Research Site

    Myrtle Beach, South Carolina · Not yet recruiting

  • Research Site

    Memphis, Tennessee · Not yet recruiting

  • Research Site

    Houston, Texas · Not yet recruiting

  • Research Site

    Round Rock, Texas · Not yet recruiting

  • Research Site

    San Antonio, Texas · Not yet recruiting

  • Research Site

    Renton, Washington · Not yet recruiting

  • Research Site

    Campbelltown, Australia · Not yet recruiting

  • Research Site

    East Toowoomba, Australia · Recruiting

  • Research Site

    Heidelberg Heights, Australia · Not yet recruiting

  • Research Site

    Parkville, Australia · Not yet recruiting

  • Research Site

    St Leonards, Australia · Not yet recruiting

  • Research Site

    Dupnitsa, Bulgaria · Not yet recruiting

  • Research Site

    Kozloduy, Bulgaria · Not yet recruiting

  • Research Site

    Plovdiv, Bulgaria · Not yet recruiting

  • Research Site

    Sofia, Bulgaria · Not yet recruiting

  • Research Site

    Stara Zagora, Bulgaria · Not yet recruiting

  • Research Site

    Veliko Tarnovo, Bulgaria · Not yet recruiting

  • Research Site

    Yambol, Bulgaria · Not yet recruiting

  • Research Site

    Surrey, British Columbia, Canada · Not yet recruiting

  • Research Site

    Vancouver, British Columbia, Canada · Recruiting

  • Research Site

    Brampton, Ontario, Canada · Not yet recruiting

  • Research Site

    North York, Ontario, Canada · Not yet recruiting

  • Research Site

    Sarnia, Ontario, Canada · Not yet recruiting

  • Research Site

    Scarborough Village, Ontario, Canada · Not yet recruiting

  • Research Site

    Toronto, Ontario, Canada · Recruiting

  • Research Site

    Saint-Charles-Borromée, Quebec, Canada · Not yet recruiting

  • Research Site

    Changsha, China · Not yet recruiting

  • Research Site

    Changsha, China · Not yet recruiting

  • Research Site

    Hefei, China · Not yet recruiting

Showing 40 of 132 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.